The initial public offer of vaccine manufacturing firm GreenSignal Bio Pharma received a lukewarm response from investors as it got subscribed just 82 per cent on the last day today.
The Rs 112-crore IPO received bids for 23,62,500 shares as against the total issue size of 1,19,08,750 shares, data available with the NSE till 1700 hrs showed.
Till yesterday, portion set aside for non institutional investors was subscribed 2 per cent, while that of retail investors got oversubscribed 1.59 times.
The company has entered the capital market with its IPO of 1,45,79,560 shares of face value of Rs 10 each through an offer for sale. It has fixed the price band at Rs 76-80.
The shares are proposed to be listed on BSE and NSE.
The firm is into manufacturing of BCG vaccine given for protection against tuberculosis, mainly severe forms of child tuberculosis.
Disclaimer: No Business Standard Journalist was involved in creation of this content
